Regulatory Requirements for Viral Vector Production Platforms

In this webinar, Regulatory requirements for viral vector production platforms, speakers Scott Cross from Dark Horse Consulting Group, and Thermo Fisher’s Shikha Mishra share their thoughts on regulatory compliance throughout the therapeutic development lifecycle and advise on best practices for producing high-quality viral vectors at scale.

You’ll learn:

  • Key regulatory and quality requirements across gene therapy workflows, and the associated challenges faced by manufacturers today 
  • Navigating the path from research and discovery to clinical and commercial manufacturing 
  • Innovative and compliant solutions in viral vector manufacturing

    What phase of development is your program currently in?

    Yes, I'm interested in scheduling a product demo or requesting pricing information.

    What is your Biggest Pain Point or Challenge?

    I agree for the Thermo Fisher Scientific group (thermofisher.com/legal entities) to contact me by e-mail and telephone to inform me of events, products, services and promotions offered in connection with the brands Thermo Scientific™, Applied Biosystems™, Invitrogen™, Gibco™, Ion Torrent™, Unity Lab Services™, Fisher Scientific™. I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com.

    What gene modification modality are you working with?




    All information that you supply is protected by our Privacy Policy.
    In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
    By submitting your information you agree to our Terms of Use.
    Third party cookies may be placed, to serve more relevant ads when you browse the web.
    You can learn more about those ads here.